<DOC>
	<DOCNO>NCT00299624</DOCNO>
	<brief_summary>Aging independent risk factor , without clear explanation . The primary aim study depict effect age coagulation fibrinolysis parameter microparticles .</brief_summary>
	<brief_title>Effect Aging Haemostasis Parameters</brief_title>
	<detailed_description>Patients old 40 , without acute disease receive antiaggregant anticoagulant therapy include study . Blood test perform coagulation , fibrinolysis microparticles measurement .</detailed_description>
	<criteria>age &lt; 40 2 group : 1 : history VTE 2 : history VTE antiaggregant anticoagulant therapy curative dose arterial thrombotic event last month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>venous thromboembolism risk ,</keyword>
	<keyword>elderly ,</keyword>
	<keyword>hypercoagulability</keyword>
	<keyword>fibrinolysis</keyword>
	<keyword>microparticles</keyword>
</DOC>